Why Clinical Trial Translations Matter

When clinical trial sites, sponsors and tech vendors think about diversity and inclusion, we consider a variety of factors: age, race, ethnicity, gender identity, sexual orientation, ability, and...

How “frontier sites” and hybrid clinical trials can help research sites

The number of clinical trials has increased rapidly since 2020. 2021 saw a 14% increase in trial starts over 2020 and a 19% increase over 2019. And while 2020 was far from a typical year, the...

How eConsent Can Help Legally Authorized Representatives in Clinical Trials

A legally authorized representative (LAR) has a vital role to play in clinical trials, yet clinical trial software vendors too often forget to think about LARs and their needs.  Most clinical...

FDA Guidance for Diversity in Clinical Trials: What You Need to Know

The FDA’s newest guidance, “Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials,” took the clinical research world by...

4 Trends in Clinical Research You Need to Know About from ACRP 2022

Wondering what’s next in the world of clinical research? Catherine Gregor, Florence’s Chief Clinical Trial Officer and the former Director of Clinical Research Administration at Vanderbilt,...

6 Events You Won’t Want to Miss at ACRP 2022

First clinical trial site to adopt Florence eConsent successfully registers 250 patients in 1 month

ATLANTA–(Business Wire)--The first research site to adopt Florence eConsent has successfully registered 250 patients after just 30 days of using the platform. Florence designed eConsent to speed...

How Digital Connections Can Create a Positive Patient Experience in Clinical Trials

Patient experience in clinical trials is a problem. On patient satisfaction surveys, clinical trials received low scores similar to the scores of Internet service providers, utility companies, and...

What eConsent Software Does for Clinical Trial Professionals

By Andrea Bastek, PhD, Sr. Direction of Innovation at Florence and former Assoc. Director of Clinical Affairs for Abbott  82% of sponsors and 88% of research sites plan to have eConsent software...

Clinical Trial Diversity: Lessons Learned from a Pandemic

Sites and sponsors struggled with clinical trial diversity long before the COVID-19 pandemic began. Roughly 20% of new drugs have different effects depending on a person’s race. This makes it...

New Year, New You? Using Change Management for Digital Clinical Trial Transformations

By Rachelle Stover, MPH, CCMP With the start of a new year, both people and organizations begin thinking about change. Perhaps there’s a new technology or software your clinical trial organization...

FAQ for the FDA’s New Guidance on Digital Health Technologies

89% of sponsors now embrace decentralized clinical trials (DCTs). With DCTs becoming commonplace, sites, sponsors and CROs have turned to the FDA for guidance on how to use clinical trial...

Are Clinical Trial Teams Prepared for ICH E6(R3)?

ICH E6(R2), the current global standard for good clinical practice (GCP), went through an update in 2016–and it’s already undergoing another major revision. With how quickly changes are happening,...

3 Ways eConsent Can Help You Earn IRB Approval

by Crystal Stargell, Associate Product Manager for Florence and former Clinical Regulatory Coordinator Informed consent is arguably the most important element of clinical research. It’s during the...

Helping Your Research Site Go Paperless

In November 2021, Florence hosted over 200 clinical research professionals at the first-ever Innovation Summit to discuss the latest trends in clinical trials.  Going paperless was the most...